These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8797688

  • 1. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):68-77. PubMed ID: 8797688
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M, Runganga J, Barbara JA, Contreras M, Tedder RS, Garson JA, Tuke PW, Mortimer PP, McAlpine L, Tosswill JH.
    BMJ; 1993 Nov 13; 307(6914):1235-9. PubMed ID: 8281054
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R, Turhan A, Bozkurt H, Samlıoğlu P, Değirmenci A, Aydınok Y, Erensoy S.
    Mikrobiyol Bul; 2010 Oct 13; 44(4):579-84. PubMed ID: 21063970
    [Abstract] [Full Text] [Related]

  • 9. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
    Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE.
    N Engl J Med; 1992 Feb 06; 326(6):375-80. PubMed ID: 1729620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the South Bronx, New York.
    Factor SH, Irwin KL, Lal RB, Rudolph D, Weber TJ, Olivo N, Ernst J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May 01; 12(1):97-7. PubMed ID: 8624769
    [No Abstract] [Full Text] [Related]

  • 13. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
    Stigum H, Magnus P, Samdal HH, Nord E.
    Int J Epidemiol; 2000 Dec 01; 29(6):1076-84. PubMed ID: 11101551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
    Khabbaz RF, Douglas JM, Judson FN, Spiegel RA, St Louis ME, Whittington W, Hartley TM, Lairmore M, Kaplan JE.
    J Infect Dis; 1990 Jul 01; 162(1):241-4. PubMed ID: 2192006
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France.
    Vignoli C, De Lamballerie X, Zandotti C, De Chesse R, Tamalet C, De Micco P.
    Eur J Epidemiol; 1995 Feb 01; 11(1):93-4. PubMed ID: 7489782
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.
    Lee HH, Swanson P, Rosenblatt JD, Chen IS, Sherwood WC, Smith DE, Tegtmeier GE, Fernando LP, Fang CT, Osame M.
    Lancet; 1991 Jun 15; 337(8755):1435-9. PubMed ID: 1675317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.